Lyric Health Appoints Bill Schmitt as Chief Growth Officer to Accelerate AI-Powered Virtual Care Growth

1 week ago

MCKINNEY, Texas, Jan. 30, 2026 /PRNewswire/ -- Lyric Health, a leader in AI-powered virtual care and integrated health navigation, today announced…

Activity Connection and Zinnia TV Partner to Advance Person-Centered Care in Senior Living Through Integrated Life Enrichment and Digital Engagement

1 week ago

VANCOUVER, Wash., Jan. 30, 2026 /PRNewswire/ -- Activity Connection and Zinnia TV today announced a strategic partnership to integrate structured…

Soundtrace Completes Independent Third-Party Review Confirming Alignment With OSHA Hearing Conservation Requirements

1 week ago

Former Senior OSHA Leader Evaluates Program Against 29 CFR 1910.95CINCINNATI, Jan. 30, 2026 /PRNewswire/ -- Soundtrace, a technology-enabled services company…

Breg Achieves HITRUST Certification for Breg Vision® and Vision Clarity™

1 week ago

CARLSBAD, Calif., Jan. 30, 2026 /PRNewswire/ -- Breg today announced that it has successfully achieved HITRUST certification, underscoring the company's…

Understanding When to Use Fillers or Neurotoxins According to Dr. Ran Rubinstein

1 week ago

Dr. Ran Rubinstein discusses how individualized treatment planning determines when fillers, neurotoxins, or collagen-stimulating injectables are most appropriate. MONTVALE, NEW…

Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets

1 week ago

PALO ALTO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative…

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

1 week ago

TAIZHOU, China, Jan. 30, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”),  a specialty…

Amplia Therapeutics – Quarterly Activities and Cash Flow Reports – December 2025

1 week ago

Melbourne, Australia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Key Highlights from the Quarter ACCENT Trial Success: The ACCENT trial, testing…

ALX Oncology Announces Pricing of Underwritten Offering

1 week ago

SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage…

Ultragenyx Resubmits Biologics License Application for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) to U.S. FDA

1 week ago

Company expects up to six-month review period per FDA guidelines  New longer-term clinical data demonstrating durable positive brain biochemical and…